Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study

by Christina Yek, Carolina de la Flor, John Marshall, Cindy Zoellner, Grace Thompson, Lisa Quirk, Christian Mayorga, Barbara J. Turner, Amit G. Singal, Mamta K. Jain
Published 2017-11-01

Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis.

by Huw Price, David Dunn, Deenan Pillay, Firouze Bani-Sadr, Theodora de Vries-Sluijs, Mamta K Jain, Noriyoshi Kuzushita, Stefan Mauss, Marina Núñez, Reto Nüesch, Marion Peters, Thomas Reiberger, Christoph Stephan, Lionel Tan, Richard Gilson
Published 2013-01-01

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens.

by Gregory D Huhn, Moti Ramgopal, Mamta K Jain, Federico Hinestrosa, David M Asmuth, Jihad Slim, Deborah Goldstein, Shauna Applin, Julie H Ryu, Shuping Jiang, Stephanie Cox, Moupali Das, Thai Nguyen-Cleary, David Piontkowsky, Bill Guyer, Lorenzo Rossaro, Richard H Haubrich
Published 2020-01-01